$EXFY

Alvarez Divo Carlos Eduardo sold $16K of EXFY

Alvarez Divo Carlos Eduardo sold 20,380 shares of Expensify, Inc. (EXFY) at an average of $0.80 ($0.76–$0.84) across 3 trades over 2026-03-17 to 2026-03-30.

Original reporting
SEC EDGAR · Alvarez Divo Carlos Eduardo
Published Jun 11, 2026, 10:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 11:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$EXFY
Neutral
high confidence
Mentioned
$EXFY
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXFYNeutralLow
01

Why it matters

Traders may monitor for patterns of insider selling, but this single, modest sale does not introduce new operating or financial information.

02

Market read

A director’s open-market sale totaling ~$16.2k is disclosed; likely limited incremental impact absent other catalysts.

03

What to watch

No 10b5-1 plan is stated; however, the absence of a plan does not by itself imply insider conviction without additional context (e.g., repeated sales, size vs. holdings, or concurrent fundamental news).

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-11 for sales executed 2026-03-17 to 2026-03-30

Background

The article is an SEC Form 4 insider transaction disclosure for Expensify, Inc. (EXFY).

Company-level read

Ticker impact

$EXFYNeutralHigh confidence
Context

Expensify director Alvarez Divo sold 20,380 shares in open-market transactions totaling $16,247, with no 10b5-1 plan disclosed.

Expected impact

Low likelihood of sustained price impact; any effect is likely short-lived unless paired with other news.

Evidence & confidence

The filing is a disclosed sale by a director, but it does not include earnings, guidance, regulatory action, or deal terms—so the incremental information is limited.

Market effects

Minimal—this is company-specific insider activity with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

Because the sale occurred earlier (March) and is small, it may reflect diversification or liquidity needs rather than bearish expectations.

Key entities

  • Expensify, Inc.

    Company whose director reported an open-market sale of shares via SEC Form 4.

  • Alvarez Divo Carlos Eduardo

    Director who sold 20,380 shares across three trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EXFYMedAI 9/10

Expensify (EXFY) Q2 2026 Earnings Call Transcript

Expensify (EXFY) reported Q2 2026 revenue of $33.9M, down 5% year over year, with paid members at 640,000, down 2%. Interchange revenue rose 12% to $5.9M. Free cash flow guidance for fiscal 2026 was raised to $12M to $14M. The company also repurchased 6.8M shares and said new revenue comes from the New Expensify platform.

Med

Expensify: New Platform Revenue Surges Over 250% As AI Agents Connect With ChatGPT, Claude And Cursor

Expensify reported New Expensify net-new customer revenue rose more than 250% year over year to over $10 million in annual recurring revenue, exceeding 10,000 new accounts. Overall quarterly revenue fell 5% to $33.9 million. Expensify launched Expensify MCP connecting to ChatGPT, Claude and Cursor. Interchange revenue rose 12% to $5.9 million; free cash flow was $6.4 million. Expensify repurchased ~6.8M Class A shares.

$EXFYMed

Expensify Reports Q2 2026 Results, Highlights New Platform

Expensify (EXFY) reported Q2 2026 results on Aug. 6. Net revenue fell 5% Y/Y to $33.9M. Net loss narrowed to $3.9M, while non-GAAP net income was $3.4M. Operating cash was $8.4M and free cash flow $6.4M. Interchange revenue rose 12% to $5.9M. The company repurchased 6.8M Class A shares and said annual recurring revenue from New Expensify exceeded $10M.

$EXFYMed

Citizens upgrades Expensify stock rating on growth outlook

Citizens upgraded Expensify Inc (NASDAQ:EXFY) to Market Outperform from Market Perform and set a $3.00 price target. The firm cited expectations for a return to growth after 13 quarters of contraction, plus Q2 2026 metrics including over $10M New Expensify ARR and 45,700 paid companies. Expensify reported $33.9M revenue, -$0.04 adjusted EPS, and raised its free cash flow outlook.

$EXFYHighAI 9/10

Expensify Inc (EXFY) (Q2 2026) Earnings Call Highlights: AI-Driven New Expensify Surges 250%

Expensify’s Q2 2026 earnings call said new Expensify ARR rose from about $7M at end of Q1 to about $12M at end of Q2, growing over 250% year over year. The company said over 56% of users are on new Expensify and virtually all incremental revenue comes from it. Full-year 2026 free cash flow guidance was raised to $12M-$14M. Q2 revenue was $33.9M and FCF $6.4M.